IL121647A - Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate - Google Patents

Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate

Info

Publication number
IL121647A
IL121647A IL12164797A IL12164797A IL121647A IL 121647 A IL121647 A IL 121647A IL 12164797 A IL12164797 A IL 12164797A IL 12164797 A IL12164797 A IL 12164797A IL 121647 A IL121647 A IL 121647A
Authority
IL
Israel
Prior art keywords
dexamethasone
treatment
oil
ester
composition
Prior art date
Application number
IL12164797A
Other languages
English (en)
Other versions
IL121647A0 (en
Original Assignee
Pharmateam Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmateam Dev Ltd filed Critical Pharmateam Dev Ltd
Priority to IL12164797A priority Critical patent/IL121647A/en
Publication of IL121647A0 publication Critical patent/IL121647A0/xx
Priority to AU88839/98A priority patent/AU8883998A/en
Priority to EP98940536A priority patent/EP1009409A1/en
Priority to JP2000508372A priority patent/JP2001514228A/ja
Priority to CA002300850A priority patent/CA2300850A1/en
Priority to PCT/IL1998/000411 priority patent/WO1999011270A1/en
Priority to CN98809486A priority patent/CN1271288A/zh
Publication of IL121647A publication Critical patent/IL121647A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12164797A 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate IL121647A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
AU88839/98A AU8883998A (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate
EP98940536A EP1009409A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
JP2000508372A JP2001514228A (ja) 1997-08-28 1998-08-26 パルミチン酸デキサメタゾンを含有する眼炎症を治療するための薬学的組成物
CA002300850A CA2300850A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
PCT/IL1998/000411 WO1999011270A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
CN98809486A CN1271288A (zh) 1997-08-28 1998-08-26 治疗眼部炎症的含有地塞米松棕榈酸酯的药用组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate

Publications (2)

Publication Number Publication Date
IL121647A0 IL121647A0 (en) 1998-02-08
IL121647A true IL121647A (en) 2001-07-24

Family

ID=11070569

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate

Country Status (7)

Country Link
EP (1) EP1009409A1 (zh)
JP (1) JP2001514228A (zh)
CN (1) CN1271288A (zh)
AU (1) AU8883998A (zh)
CA (1) CA2300850A1 (zh)
IL (1) IL121647A (zh)
WO (1) WO1999011270A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100355455C (zh) * 2002-07-15 2007-12-19 爱尔康公司 用于眼内使用的非聚合亲脂性药物植入组合物
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
EP2319517B1 (en) * 2006-06-01 2013-09-11 Novagali Pharma S.A. Use of prodrugs for ocular intravitreous administration
KR101541416B1 (ko) 2006-06-01 2015-08-03 산텐 에스에이에스 후안부 질환 치료를 위한 스테로이드 전구약물의 용도
KR101805116B1 (ko) * 2007-12-04 2017-12-06 산텐 에스에이에스 덱사메타손 팔미테이트와 같은 코르티코스테로이드 전구약물을 포함하는 안과질환 치료용 조성물
CN108434090A (zh) * 2017-02-14 2018-08-24 高药品股份有限公司 以生理脂肪为基剂的类固醇药膏

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JPH05124965A (ja) * 1991-11-06 1993-05-21 L T T Kenkyusho:Kk 局所用鼻・気管支疾患治療剤

Also Published As

Publication number Publication date
IL121647A0 (en) 1998-02-08
CN1271288A (zh) 2000-10-25
EP1009409A1 (en) 2000-06-21
CA2300850A1 (en) 1999-03-11
JP2001514228A (ja) 2001-09-11
WO1999011270A1 (en) 1999-03-11
AU8883998A (en) 1999-03-22

Similar Documents

Publication Publication Date Title
EP0041772B1 (en) Fat emulsion containing a steroid
RU2048812C1 (ru) Способ лечения воспалительных заболеваний глаза и средство для лечения воспалительных заболеваний глаза
EP1781278B1 (en) Compositions and methods for treating eye disorders and conditions
Forrester et al. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats
EP0093380A2 (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US20210353770A1 (en) Delivery of Urea to Cells of the Macula and Retina Using Liposome Constructs
JP2003523925A (ja) 乾燥性眼病の局所治療のためのテトラサイクリンを含む眼科用溶液
US20070265341A1 (en) Compositions and methods for treating eye disorders and conditions
Badr et al. A polymeric aqueous tacrolimus formulation for topical ocular delivery
US8470997B2 (en) Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
IL121647A (en) Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
WO1994004155A1 (en) Dehydroepiandrosterone therapy for the treatment of eye disorders
Cannon et al. Reduction of pain on intravenous infusion with bile salt formulations for a macrolide antibiotic
Hayasaka et al. Ocular changes after intravitreal injection of methanol, formaldehyde, or formate in rabbits
US20050113311A1 (en) Composition and method for the treatment of eye disease
MXPA00001942A (en) Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
Jahn et al. Lipid composition of human aqueous humor
JPH08508975A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
New et al. Intestinal delivery of calcitonin in pig
ELLIS et al. Comparative intraocular levels of pilocarpine achieved with drops and repository preparations
AU2002309963B2 (en) Use of NF-KAPPA-B inhibitors to treat dry eye disorders
Nagata et al. A mild progression type of naphthalene-induced cataract in Brown-Norway rats
JPH1160491A (ja) アムホテリシンｂ含有製剤
US20150174122A1 (en) Methods for treating eye disorders using opioid receptor antagonists
AU2002309963A1 (en) Use of NF-KAPPA-B inhibitors to treat dry eye disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force